Theme-Logo
  • All Specialties
    • Category 1
    • Category 2
      • 2nd level dropdown
      • 2nd level dropdown
    • Category 3
      • 3nd level dropdown
      • 3nd level dropdown

A report of the article titled Therapeutic efficacy of pH-dependent-release formulation of mesalamine on active ulcerative colitis resistant to time-dependent-release formulation: Analysis of faecal calprotectin concentration

pH-dependent-release mesalamine effective for ulcerative colitis resistant to time-dependent-release mesalamine

  • 138 Views
0 0


Comments

  • User Name

Denosumab an alternative option to zoledronic acid for SRE prevention in multiple myeloma
96 Views 0 0
Denosumab shows long-term disease control in resectable and unresectable giant-cell tumour of bone
18 Views 5 0
Evolocumab reduces MACE and coronary revascularization in patients with prior PCI
30 Views 0 0
Larger early LDL-C reduction, more intensive statin therapy cut CV and death risks
17 Views 0 0
LDL-C levels after PCI predictive of future adverse CV events
54 Views 0 0
Long-term evolocumab is well tolerated, shows greater CV event reduction than delayed initiation
1 Views 0 0
pH-dependent-release mesalamine effective for ulcerative colitis resistant to time-dependent-release mesalamine
138 Views 0 0
pH-dependent-release mesalamine leads to high mucosal levels in ulcerative colitis
46 Views 0 0
×

About Us

pubthree™️ is an independent video news channel reporting on clinical and research findings from leading medical journals in an explainer video... View more

Information
  • About Us
  • Sponsorship
  • Careers
  • Contact Us
Legal Terms
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
copyright © 2025, Silverback Communications Sdn Bhd